Ashley Bloomfield

From WikiMD's WELLNESSPEDIA

Ashley Bloomfield is a New Zealand public health physician and public servant. He has been serving as the Director-General of Health, the chief executive of the Ministry of Health, since June 2018. Bloomfield has been at the forefront of New Zealand's public health response to the COVID-19 pandemic.

Early life and education[edit]

Bloomfield was born and raised in Wellington, New Zealand. He completed his undergraduate medical training at the University of Auckland in 1990. He later received a Master's degree in Public Health from the University of Otago, Wellington in 1998.

Career[edit]

Bloomfield began his career as a clinical doctor, before moving into public health roles. He has held a number of senior leadership positions within the New Zealand health sector, including as the Chief Executive at Capital and Coast District Health Board and acting Deputy Director-General in the Ministry of Health’s Policy Business Unit.

In June 2018, Bloomfield was appointed as the Director-General of Health, becoming the chief executive of the Ministry of Health. In this role, he has been responsible for the overall management and stewardship of the health and disability system in New Zealand.

During the COVID-19 pandemic, Bloomfield has been a key figure in New Zealand's response, providing regular updates and advice to the public. His leadership during this time has been widely praised both nationally and internationally.

Personal life[edit]

Bloomfield is married and has three children. He is known for his interest in sports, particularly football, and is a supporter of the Wellington Phoenix football team.

See also[edit]

References[edit]


External links[edit]

Stub icon

This New Zealand biographical article is a stub. You can help WikiMD by expanding the page.

Stub icon

This article about the COVID-19 pandemic is a stub. You can help WikiMD by expanding the page.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Ashley_Bloomfield&oldid=6318800"